Advertisement Dalton Pharma to offer aseptic fill-finish services to AdeTherapeutics - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Dalton Pharma to offer aseptic fill-finish services to AdeTherapeutics

Dalton Pharma Services has signed a clinical manufacturing servicing agreement with AdeTherapeutics, under which Dalton is expected to offer aseptic fill/finish services under cGMP, for ADE's sterile anti-adhesion (scar tissue reduction) product.

AdeTherapeutics is a specialty pharma company based in Saskatoon, Saskatchewan, focused on providing quality therapeutic options in inflammation and acute care medicine.

AdeTherapeutics president and CEO Sanj Singh said that the partnership with Dalton is a key part of AdeTherapeutics capital efficient virtual drug development model where they work with expert service providers from all over the globe to bring their novel therapeutics and diagnostics forward benefiting the healthcare community with safe, reliable and cost-effective treatment choices.